Isabelle Texier results 4
· Newest (Page 1/1, per page 25)
Author: Isabelle Texier ×Clear All Filters
Search Results
Biodistribution of nanoencapsulated bioactive compounds is primarily determined by the size, shape, chemical composition and surface properties of the encapsulating nanoparticle, and, thus, less dependent on the physicochemical properties of the active pharmaceutical ingredient encapsulated. In the current work, we aimed to investigate the impact of formulation type on biodistribution profile for two clinically relevant nanofo...
A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriersNARA Subscribed
The development of drug nanocarriers based on polymeric, lipid and ceramic biomaterials has been paving the way to precision medicine, where the delivery of poorly soluble active compounds and personalized doses are made possible. However, the nano-size character of these carriers has been demonstrated to have the potential to elicit pathways of the host response different from those of the same biomaterials when engineered as...
Previous1Next